H1B Salary Data

Home › Employers › Chaparral Medical Group, Inc,

Chaparral Medical Group, Inc,: H-1B salaries and sponsorship

Chaparral Medical Group, Inc, filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $280,000.

Applications (LCAs)3
Certified3
Employer addressPomona, CA
H-1B dependent employerNo
Median offered salary$280,000
Middle half of salaries$265,000–$340,000
10th–90th percentile$256,000–$376,000

Does Chaparral Medical Group, Inc, sponsor H-1B visas?

Chaparral Medical Group, Inc, filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 15, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Physician - Interventional Cardiologist1$400,000
Physician - Internist1$250,000
Physician - Endocrinologist1$280,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$400,000
FY20241$250,000
FY20251$280,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Physician - Endocrinologist$280,000
Level III
Pomona, CAMay 15, 2025Sep 1, 2025Certified
Physician - Interventional Cardiologist$400,000Pomona, CADec 13, 2022Mar 1, 2023Certified
Physician - Internist$250,000
Level IV
Pomona, CAOct 26, 2021Dec 1, 2021Certified, then withdrawn

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).